Neuphoria Therapeutics Inc. (NEUP)
$3.39+2.11%Close
SELLBEAR · day 32
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $18M
- Beta
- 0.75
- P/E (TTM)
- -0.47
- Short % float
- 0.48%
- Days to cover
- 1.6
- SI change
- -19.0%
- 1W
- -1.74%
- 1M
- -10.79%
- vs SPY 1W
- -1.60%
- vs SPY 1M
- -13.30%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on NEUP?
- LOPJLB’s latest quantitative signal on Neuphoria Therapeutics Inc. (NEUP) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is NEUP in?
- Neuphoria Therapeutics Inc. (NEUP) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Neuphoria Therapeutics Inc. (NEUP) do?
- Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.